Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
about
Liposomal cancer chemotherapy: current clinical applications and future prospects.Receptor induction and targeted drug delivery: a new antileukaemia strategy.The transferrin receptor and the targeted delivery of therapeutic agents against cancer.The folate receptor: what does it promise in tissue-targeted therapeutics?Imaging characteristics of zinc sulfide shell, cadmium telluride core quantum dots.Environmentally responsive peptides as anticancer drug carriers.The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.Nanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectives.Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells.Liposomal siRNA nanocarriers for cancer therapy.Efficacy of immunoliposomes on cancer models in a cell-surface-antigen-density-dependent manner.Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine.The achievement of ligand-functionalized organic/polymeric nanoparticles for treating multidrug resistant cancer.Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia.Targeting of daunomycin using biotinylated immunoliposomes: pharmacokinetics, tissue distribution and in vitro pharmacological effects.Antitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenografts.Iron metabolism and drug resistance in cancer.
P2860
Q34481466-394C677F-8898-4FE5-827E-7520883DF605Q35164785-FFB9154A-10A5-42F3-BE70-D46D19F06163Q36406637-0566CBF0-E6E8-4558-9CDF-BBA21D385EABQ36749423-9D28F9CB-572F-4D96-ABFE-0CA457B9BE84Q37167336-8A7541BA-B0FC-4BC9-852D-2A544E5C4543Q37560183-9EA43989-329B-4970-B1F4-B731AEA44EACQ37717652-565199D7-703A-4332-9DAA-961AA59FAE4AQ38059498-DF750699-F688-4B2F-AB33-5BCEFF407329Q38104410-B7D34EBC-0329-4390-9B30-20574C7ECE00Q38175250-A2C4E949-001B-4744-A847-62B37BBB89C9Q38602679-87958C2A-21A7-4A27-B4C7-A40101E368D3Q38741392-2C399FFD-E108-448D-B563-0519C5568AB0Q38809044-67D90C16-DB5D-4246-AB58-10409344116BQ40318973-7D7CDFDD-23F1-4F62-BE4C-EB21491A3B33Q44813441-FE15ACB9-1C14-468F-AEB8-CCB79E485889Q46731833-F5D62EE4-FB60-43AC-B3D6-41C0DDAA107DQ47220999-4D93157D-F57A-4D6A-B57F-921D320335E3Q48001406-2B51160E-9633-491B-8B5F-8094D0497F7F
P2860
Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Modulation of doxorubicin resi ...... rgeting transferring receptor.
@en
type
label
Modulation of doxorubicin resi ...... rgeting transferring receptor.
@en
prefLabel
Modulation of doxorubicin resi ...... rgeting transferring receptor.
@en
P2093
P2860
P356
P1476
Modulation of doxorubicin resi ...... rgeting transferring receptor.
@en
P2093
P2860
P2888
P356
10.1038/BJC.1997.340
P407
P577
1997-01-01T00:00:00Z